| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |